Xuejun Wang Selected Research

Biomarkers (Surrogate Marker)

11/2023	LncRNA-XR_002792574.1-mediated ceRNA network reveals potential biomarkers in myopia-induced retinal ganglion cell damage.
1/2021	MicroRNAs as Potential Biomarkers for the Diagnosis of Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
11/2016	Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.
5/2016	Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membrane.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuejun Wang Research Topics

Disease

46	Neoplasms (Cancer) 05/2024 - 09/2004
22	Cardiomyopathies (Cardiomyopathy) 01/2023 - 11/2003
15	Heart Diseases (Heart Disease) 03/2024 - 12/2002
15	Proteostasis Deficiencies 01/2023 - 05/2009
13	Heart Failure 01/2022 - 02/2006
12	Cardiomegaly (Heart Hypertrophy) 01/2024 - 01/2005
10	Infections 03/2024 - 04/2012
9	Myocardial Ischemia (Ischemic Heart Diseases) 12/2018 - 09/2011
8	Stomach Neoplasms (Stomach Cancer) 05/2024 - 01/2011
8	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2010
8	Cardiotoxicity 01/2022 - 12/2005
7	Inflammation (Inflammations) 05/2024 - 05/2011
7	Necrosis 03/2024 - 01/2011
7	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 05/2009
7	COVID-19 01/2022 - 12/2020
6	Reperfusion Injury 01/2021 - 11/2011
6	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2017 - 12/2002
5	Hypertrophy 01/2024 - 12/2002
5	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 04/2014
5	Hypertension (High Blood Pressure) 01/2022 - 06/2003
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017 - 01/2014
4	Body Weight (Weight, Body) 11/2023 - 09/2007
4	Ischemic Stroke 07/2022 - 02/2014
4	Hypoxia (Hypoxemia) 01/2021 - 01/2013
4	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2014
4	Pathologic Processes 01/2021 - 12/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2019 - 01/2017
4	Leukemia 09/2018 - 11/2014
3	Fibrosis (Cirrhosis) 05/2024 - 01/2013
3	Hypospadias 01/2024 - 01/2019
3	Virus Diseases (Viral Diseases) 06/2023 - 06/2022
3	Altitude Sickness (Mountain Sickness) 10/2022 - 01/2014
3	Stroke (Strokes) 07/2022 - 02/2014
3	Ischemia 01/2021 - 12/2004
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 11/2005
3	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 05/2009
3	Multiple Myeloma 01/2018 - 06/2014
3	Lymphatic Metastasis 02/2017 - 02/2014
3	Desmin-Related Myofibrillar Myopathy 02/2006 - 12/2004
2	Myocarditis (Carditis) 05/2024 - 02/2011
2	Port-Wine Stain (Nevus Flammeus) 12/2023 - 06/2023

Drug/Important Bio-Agent (IBA)

58	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2024 - 09/2004
55	Proteins (Proteins, Gene)FDA Link 04/2024 - 12/2002
27	UbiquitinIBA 01/2024 - 04/2006
15	DesminIBA 12/2017 - 12/2002
12	Deubiquitinating EnzymesIBA 05/2019 - 06/2014
11	Messenger RNA (mRNA)IBA 05/2024 - 01/2012
9	Protein AggregatesIBA 04/2023 - 04/2006
9	Ubiquitinated ProteinsIBA 12/2018 - 11/2005
7	MicroRNAs (MicroRNA)IBA 05/2024 - 01/2012
7	Peptides (Polypeptides)IBA 05/2024 - 01/2020
7	Crystallins (Crystallin)IBA 01/2021 - 12/2002
7	Proteasome InhibitorsIBA 01/2020 - 01/2012
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 12/2005
5	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 09/2016
5	Indicators and Reagents (Reagents)IBA 01/2024 - 05/2014
5	Auranofin (Ridaura)FDA Link 03/2019 - 07/2014
5	Bortezomib (Velcade)FDA Link 09/2018 - 01/2013
5	CaspasesIBA 01/2018 - 01/2014
5	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 01/2014
5	gambogic acidIBA 04/2015 - 01/2013
4	Antiviral Agents (Antivirals)IBA 03/2024 - 04/2012
4	Biomarkers (Surrogate Marker)IBA 11/2023 - 05/2016
4	CopperIBA 11/2023 - 06/2014
4	salicylhydroxamic acid (SHAM)IBA 01/2023 - 12/2008
4	BilirubinIBA 01/2021 - 01/2017
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2013
4	Androgen Receptors (Androgen Receptor)IBA 05/2019 - 01/2017
4	GoldIBA 01/2018 - 07/2014
4	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 06/2014
3	Mechanistic Target of Rapamycin Complex 1IBA 03/2024 - 12/2017
3	CytokinesIBA 01/2023 - 10/2014
3	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2016
3	Sildenafil Citrate (Viagra)FDA Link 10/2022 - 07/2013
3	Transcription Factors (Transcription Factor)IBA 06/2022 - 01/2016
3	Nucleic AcidsIBA 01/2022 - 10/2021
3	Cullin Proteins (Cullins)IBA 01/2021 - 01/2011
3	Coordination ComplexesIBA 01/2018 - 06/2014
3	bcr-abl Fusion ProteinsIBA 01/2017 - 01/2014
3	ATP dependent 26S protease (26S proteasome)IBA 09/2016 - 05/2009
3	Antirheumatic Agents (DMARD)IBA 11/2014 - 07/2014
2	Circular RNAIBA 05/2024 - 01/2021
2	TetraspaninsIBA 04/2024 - 01/2018
2	Adenosine Triphosphatases (ATPase)IBA 04/2024 - 11/2005
2	Evans Blue (Blue, Evans)FDA Link 03/2024 - 01/2020
2	Coloring Agents (Dyes)IBA 03/2024 - 01/2020
2	CatecholaminesIBA 03/2024 - 01/2021
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2024 - 01/2013
2	hematoporphyrin monomethyl etherIBA 12/2023 - 06/2023
2	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2022
2	Long Noncoding RNAIBA 11/2023 - 12/2018
2	MetalsIBA 11/2023 - 09/2023
2	EnzymesIBA 01/2023 - 10/2022

Therapy/Procedure

23	Therapeutics 11/2023 - 12/2005
7	Gastrectomy 05/2024 - 06/2013
7	Drug Therapy (Chemotherapy) 01/2022 - 04/2015
4	Photothermal Therapy 01/2020 - 10/2017
3	Ligation 04/2023 - 07/2017
2	Length of Stay 05/2024 - 12/2020
2	Photochemotherapy (Photodynamic Therapy) 12/2023 - 06/2023